Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

New health startups dealing with increased FDA scrutiny

As more health-related tech startups emerge in Silicon Valley, the FDA and other government agencies are stepping up their presence in the region like never before.

Study: Increased spending on social services improves health

States that increased spending on public health and social services programs between 2000 and 2009 saw significant improvement in health outcomes in areas such as adult obesity and asthma.

Joint Commission reverses course, OKs secure clinician texting

The commission's update allows for clinician texting and messaging for “care, treatment, and services…across all accreditation programs.”

States improve quality, reduce costs via reform

States that have implemented health reform options have reduced costs while also maintaining or even improving the quality of care.

NY med schools: clerkships are scarce because of offshore competition

Medical school students in New York are having trouble finding available clinical clerkships because for-profit, offshore medical schools are paying for slots.

Proposed change to Medicare Part B finding little support in Congress

Pilot program would reduce the 6 percent add-on to the average sales price to 2.5 percent plus a flat fee of $16.80 per drug per day

Joint Commission announces new standards on treating eating disorders

Behavioral health care organizations treating eating disorders will be subject to several additional requirements from the Joint Commission.

CMS clarifies Medicaid rules on ex-prisoners in halfway houses

New CMS guidelines for state health officials means 96,000 ex-prisoners currently living in halfway houses can receive Medicaid services.

Displaying 2561 - 2568 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup